Financial Ratios

VIMTA LABS LTD.

NSE : VIMTALABSBSE : 524394ISIN CODE : INE579C01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE460.00-0.55 (-0.12 %)
PREV CLOSE ( ) 460.55
OPEN PRICE ( ) 462.35
BID PRICE (QTY) 459.25 (3)
OFFER PRICE (QTY) 460.00 (222)
VOLUME 1378
TODAY'S LOW / HIGH ( )459.00 466.50
52 WK LOW / HIGH ( )346.65 621.4
NSE461.651.45 (+0.32 %)
PREV CLOSE( ) 460.20
OPEN PRICE ( ) 460.20
BID PRICE (QTY) 461.80 (32)
OFFER PRICE (QTY) 462.60 (1)
VOLUME 7209
TODAY'S LOW / HIGH( ) 459.05 465.90
52 WK LOW / HIGH ( )347.3 623.15
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)21.3718.579.623.1311.45
   CEPS(Rs)35.1729.0419.9912.6020.37
   DPS(Rs)2.002.002.000.002.00
   Book NAV/Share(Rs)123.92104.3787.8978.2377.59
   Tax Rate(%)25.9025.8225.1317.0027.97
Margin Ratios
   Core EBITDA Margin(%)29.6928.9025.2016.6127.06
   EBIT Margin(%)21.1020.6014.626.7018.69
   Pre Tax Margin(%)20.2620.0613.584.6216.53
   PAT Margin (%)15.0114.8810.173.8311.90
   Cash Profit Margin (%)24.7023.2721.1415.4121.18
Performance Ratios
   ROA(%)14.3314.258.242.8810.78
   ROE(%)18.7319.3211.584.0215.64
   ROCE(%)24.2523.8514.246.0120.42
   Asset Turnover(x)0.950.960.810.750.91
   Sales/Fixed Asset(x)1.111.141.010.961.23
   Working Capital/Sales(x)2.973.573.624.694.34
Efficiency Ratios
   Fixed Capital/Sales(x)0.900.870.991.040.81
   Receivable days90.8299.27114.25117.3898.23
   Inventory Days23.1621.1727.7336.5432.02
   Payable days0.000.001516.570.00-5630.99
Valuation Parameters
   PER(x)14.7016.9716.7418.9117.46
   PCE(x)8.9310.858.054.709.81
   Price/Book(x)2.543.021.830.762.58
   Yield(%)0.640.631.240.001.00
   EV/Net Sales(x)2.132.551.810.872.18
   EV/Core EBITDA(x)6.928.677.084.757.81
   EV/EBIT(x)10.1012.3912.4012.9511.69
   EV/CE(x)1.892.321.390.641.96
   M Cap / Sales2.212.521.700.732.08
Growth Ratio
   Net Sales Growth(%)14.1832.0215.71-15.0315.91
   Core EBITDA Growth(%)19.4451.8261.96-44.4627.99
   EBIT Growth(%)16.9485.98152.37-69.5329.20
   PAT Growth(%)15.2093.12206.91-72.6354.03
   EPS Growth(%)15.1093.12206.92-72.6354.03
Financial Stability Ratios
   Total Debt/Equity(x)0.050.080.150.190.15
   Current Ratio(x)2.872.642.091.672.13
   Quick Ratio(x)2.472.271.821.371.69
   Interest Cover(x)25.1438.0014.103.228.63
   Total Debt/Mcap(x)0.020.030.080.250.06

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.